首页 | 本学科首页   官方微博 | 高级检索  
     

Ⅱ、Ⅲ期直肠癌新辅助放化疗与手术间隔时间对术后病理及临床疗效的影响
引用本文:阿衣古丽·哈热,潘广鹏,张瑾熔,伊斯刊达·阿不力米提. Ⅱ、Ⅲ期直肠癌新辅助放化疗与手术间隔时间对术后病理及临床疗效的影响[J]. 现代肿瘤医学, 2016, 0(10): 1597-1601. DOI: 10.3969/j.issn.1672-4992.2016.10.027
作者姓名:阿衣古丽·哈热  潘广鹏  张瑾熔  伊斯刊达·阿不力米提
作者单位:新疆医科大学附属肿瘤医院胸腹放疗科,新疆 乌鲁木齐 830011
基金项目:新疆维吾尔自治区卫生厅青年科技人才专项资金(编号2014Y24)
摘    要:目的:探讨局部晚期直肠癌新辅助放化疗结束与手术的间隔时间对病理及临床疗效的影响。方法:回顾性分析2010年1月至2013年7月间接受新辅助放化疗随后行根治性手术的78例初治局部晚期直肠癌患者的临床资料。根据新辅助治疗结束至手术的间隔时间中位数分为两组,A组为新辅助放化疗结束后﹤7周手术治疗38例;B组为≥7周手术治疗40例。全部患者采用三维适形调强放疗,2Gy/1次, 5次/1周,总50Gy,同步行氟尿嘧啶为基础的化疗,比较两组患者肿瘤病理退缩分级(TGR)、降期率、手术并发症发生率、局部复发率、远处转移率和生存率。结果:TRG1、TRG2、TRG3、TRG4(PCR)A组分别为 9例、7例、10例、6例,B组分别为9例、9例、12例、8例(P=0.614);T分期降期率A组63.2%,B组52.5%(P=0.368),N分期降期率A组39.5%,B组55%(P=0.039);手术并发症发生率A组18.4%,B组20%(P=0.550);3年复发率A组7.9%,B组10%(P=0.745);远处转移率A组13.2%,B组10%(P=0.663);3年生存率A组70.8%,B组84%(P=0.453)。结论:新辅助放化疗结束≥7周行手术,可以获得较高的淋巴结降期率,不增加手术难度和并发症发生率。

关 键 词:直肠肿瘤  新辅助放化疗  手术间隔时间  手术治疗

Influence of the interval between preoperative radiation therapy and surgery on postopera-tive pathology and clinical curative effect for rectal cancer
Ayiguli·Hare,Pan Guangpeng,Zhang Jinrong,Iskandar·Abulimiti. Influence of the interval between preoperative radiation therapy and surgery on postopera-tive pathology and clinical curative effect for rectal cancer[J]. Journal of Modern Oncology, 2016, 0(10): 1597-1601. DOI: 10.3969/j.issn.1672-4992.2016.10.027
Authors:Ayiguli·Hare  Pan Guangpeng  Zhang Jinrong  Iskandar·Abulimiti
Affiliation:Department of Radiation Oncology,Affiliated Tumor Hospital of Xinjiang Medical University,Xinjiang Urumqi 830011,China.
Abstract:Objective:To determine the influence of neoadjuvant chemoradiotherapy(CRT)and surgery interval on pathological and oncological outcomes. Methods:A retrospective review was performed of 78 patients with locally advanced rectal cancer underwent neoadjuvant chemoradiation followed by radical resection. The patients were dividedinto two groups according to the neoadjuvant - surgery interval < 7weeks(group A,n = 38),and≥7weeks(group B, n = 40). All patients were treated concurrently with 5 - Fluorouracil based chemotherapy and pelvic radiation(50Gy/5weeks). Pathologic and clinical coutcomes,surgical complications were compared between the two groups. Results:There was no difference in the tumor rgession grades between the two groups(TRG1,TRG2,TRG3,TRG4 were 9 ca-ses,7 cases,10 cases,6 cases in group A vs 9 cases,9 cases,12 cases,8 cases in group B respectively,P = 0. 614). Two groups were similar in terms of T - level downstaging rate(A:63. 2% vs B:52. 5% ,P = 0. 368). There was sig-nificant difference in the N downstaging rate(group A,39. 5% vs group B,55% ,P = 0. 039). The surgical complica-tions(P = 0. 550),local recurrence(P = 0. 745),distant metastasis(P = 0. 663),and overall survival(P = 0. 453) rates were not significantly different. Conclusion:A neoadjuvant - surgery interval ≥7weeks was associated with higher rates of nodal downstaging rates without increasing surgical scomplications,local recurrence and distant metas-tasis. Prolonged intervals could potentially improve survival rate.
Keywords:rectal neoplasm  neoadjuvant chemoradiotherapy  preoperative period  surgery
本文献已被 万方数据 等数据库收录!
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号